Max Christoph Liebau (Max C Liebau, Max Liebau)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 21

Top Venues

BMC nephrology

Molecular and cellular pediatrics

Scientific reports

Pediatric nephrology (Berlin, Germany)

University Hospital of Cologne

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Hospital of Cologne Jul 01 2010

Germany

Consultant Pediatric Nephrologist, Head of Experimental Pediatric Nephrology, Head Center for Chronically Ill Children :: Department of Pediatrics and Center for Molecular Medicine

University Hospital Cologne May 01 2007 - Jun 30 2010

Germany

Postdoc :: Department of Internal Medicine, Nephrology

Publications

Djalila Mekahli, Max Christoph Liebau, Melissa A Cadnapaphornchai, Stuart L Goldstein, Larry A Greenbaum, Mieczyslaw Litwin, Tomas Seeman, Franz Schaefer, Lisa M Guay-Woodford
Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease. BMC nephrology 24 (1) (2023)
Julia Etich, Oliver Semler, Nicola L Stevenson, Alice Stephan, Roberta Besio, Nadia Garibaldi, Nadine Reintjes, Claudia Dafinger, Max Christoph Liebau, Ulrich Baumann, Matthias Mörgelin, Antonella Forlino, David J Stephens, Christian Netzer, Frank Zaucke, Mirko Rehberg
TAPT1-at the crossroads of extracellular matrix and signaling in Osteogenesis imperfecta. EMBO molecular medicine (2023)
Djalila Mekahli, Max Christoph Liebau, Melissa A Cadnapaphornchai, Stuart L Goldstein, Larry A Greenbaum, Mieczyslaw Litwin, Tomas Seeman, Franz Schaefer, Lisa M Guay-Woodford
Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease. BMC nephrology 24 (1) (2023)
Stefan Kohl, Max Christoph Liebau
Fetal and Perinatal Nephrology: Small but Mighty. Kidney360 4 (3) (2023)
Djalila Mekahli, Max Christoph Liebau, Melissa A Cadnapaphornchai, Stuart L Goldstein, Larry A Greenbaum, Mieczyslaw Litwin, Tomas Seeman, Franz Schaefer, Lisa M Guay-Woodford
Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease. BMC nephrology 24 (1) (2023)
Djalila Mekahli, Max Christoph Liebau, Melissa A Cadnapaphornchai, Stuart L Goldstein, Larry A Greenbaum, Mieczyslaw Litwin, Tomas Seeman, Franz Schaefer, Lisa M Guay-Woodford
Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease. BMC nephrology 24 (1) (2023)
Valentina Capone, Nicola Persico, Alfredo Berrettini, Stèphane Decramer, Erika Adalgisa De Marco, Diego De Palma, Alessandra Familiari, Wout Feitz, Maria Herthelius, Vytis Kazlauskas, Max Christoph Liebau, Gianantonio Manzoni, Michal Maternik, Giovanni Mosiello, Joost Peter Schanstra, Johan Vande Walle, Elke Wühl, Elisa Ylinen, Aleksandra Zurowska, Franz Schaefer, Giovanni Montini
Definition, diagnosis and management of fetal lower urinary tract obstruction: consensus of the ERKNet CAKUT-Obstructive Uropathy Work Group. Nature reviews. Urology 19 (5) (2022)
Max Christoph Liebau, Erum A Hartung, Vicente E Torres
Perspectives on Drug Development in Autosomal Recessive Polycystic Kidney Disease. Clinical journal of the American Society of Nephrology : CJASN (2022)
Stefan Kohl, Fred E Avni, Peter Boor, Valentina Capone, William L Clapp, Diego De Palma, Tess Harris, Laurence Heidet, Alina C Hilger, Helen Liapis, Marc Lilien, Gianantonio Manzoni, Giovanni Montini, Susanna Negrisolo, Marie-Jeanne Pierrat, Ann Raes, Heiko Reutter, Michiel F Schreuder, Stefanie Weber, Paul J D Winyard, Adrian S Woolf, Franz Schaefer, Max Christoph Liebau
Definition, diagnosis and clinical management of non-obstructive kidney dysplasia: a consensus statement by the ERKNet Working Group on Kidney Malformations. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 37 (12) (2022)
Max Christoph Liebau
Early clinical management of autosomal recessive polycystic kidney disease. Pediatric nephrology (Berlin, Germany) 36 (11) (2021)
Claudia Dafinger, Thomas Benzing, Jörg Dötsch, Bernhard Schermer, Max Christoph Liebau
Targeted deletion of Ruvbl1 results in severe defects of epidermal development and perinatal mortality. Molecular and cellular pediatrics 8 (1) (2021)
Max Christoph Liebau, Djalila Mekahli
Translational research approaches to study pediatric polycystic kidney disease. Molecular and cellular pediatrics 8 (1) (2021)
Karl-Peter Schlingmann, François Jouret, Kuang Shen, Anukrati Nigam, Francisco J Arjona, Claudia Dafinger, Pascal Houillier, Deborah P Jones, Felix Kleinerüschkamp, Jun Oh, Nathalie Godefroid, Mehmet Eltan, Tülay Güran, Stéphane Burtey, Marie-Christine Parotte, Jens König, Alina Braun, Caro Bos, Maria Ibars Serra, Holger Rehmann, Fried J T Zwartkruis, Kirsten Y Renkema, Karin Klingel, Eric Schulze-Bahr, Bernhard Schermer, Carsten Bergmann, Janine Altmüller, Holger Thiele, Bodo Bernhard Beck, Karin Dahan, David Sabatini, Max Christoph Liebau, Rosa Vargas-Poussou, Nine V A M Knoers, Martin Konrad, Jeroen H F de Baaij
mTOR-Activating Mutations in RRAGD Are Causative for Kidney Tubulopathy and Cardiomyopathy. Journal of the American Society of Nephrology : JASN 32 (11) (2021)
Charlotte Gimpel, Max Christoph Liebau, Franz Schaefer
Systematic review on outcomes used in clinical research on autosomal recessive polycystic kidney disease-are patient-centered outcomes our blind spot? Pediatric nephrology (Berlin, Germany) 36 (12) (2021)
Claudia Dafinger, Amrei M Mandel, Alina Braun, Heike Göbel, Kathrin Burgmaier, Laura Massella, Antonio Mastrangelo, Jörg Dötsch, Thomas Benzing, Thomas Weimbs, Bernhard Schermer, Max Christoph Liebau
The carboxy-terminus of the human ARPKD protein fibrocystin can control STAT3 signalling by regulating SRC-activation. Journal of cellular and molecular medicine 24 (24) (2020)
Sophie Haumann, Roman-Ulrich Müller, Max Christoph Liebau
Metabolic Changes in Polycystic Kidney Disease as a Potential Target for Systemic Treatment. International journal of molecular sciences 21 (17) (2020)
Charlotte Gimpel, Carsten Bergmann, Detlef Bockenhauer, Luc Breysem, Melissa A Cadnapaphornchai, Metin Cetiner, Jan Dudley, Francesco Emma, Martin Konrad, Tess Harris, Peter C Harris, Jens König, Max Christoph Liebau, Matko Marlais, Djalila Mekahli, Alison M Metcalfe, Jun Oh, Ronald D Perrone, Manish D Sinha, Andrea Titieni, Roser Torra, Stefanie Weber, Paul J D Winyard, Franz Schaefer
International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people. Nature reviews. Nephrology 15 (11) (2020)
Peter Janssens, François Jouret, Bert Bammens, Max Christoph Liebau, Franz Schaefer, Ann Dandurand, Ronald D Perrone, Roman-Ulrich Müller, Christina S Pao, Djalila Mekahli
Implications of early diagnosis of autosomal dominant polycystic kidney disease: A post hoc analysis of the TEMPO 3:4 trial. Scientific reports 10 (1) (2020)
Linus Butt, David Unnersjö-Jess, Martin Höhne, Aurelie Edwards, Julia Binz-Lotter, Dervla Reilly, Robert Hahnfeldt, Vera Ziegler, Katharina Fremter, Markus M Rinschen, Martin Helmstädter, Lena K Ebert, Hayo Castrop, Matthias J Hackl, Gerd Walz, Paul T Brinkkoetter, Max Christoph Liebau, Kálmán Tory, Peter F Hoyer, Bodo B Beck, Hjalmar Brismar, Hans Blom, Bernhard Schermer, Thomas Benzing
A molecular mechanism explaining albuminuria in kidney disease. Nature metabolism 2 (5) (2020)
Kathrin Burgmaier, Samuel Kilian, Bert Bammens, Thomas Benzing, Heiko Billing, Anja Büscher, Matthias Galiano, Franziska Grundmann, Günter Klaus, Djalila Mekahli, Laurence Michel-Calemard, Gordana Milosevski-Lomic, Bruno Ranchin, Katja Sauerstein, Susanne Schaefer, Rukshana Shroff, Rosalie Sterenborg, Sarah Verbeeck, Lutz T Weber, Dorota Wicher, Elke Wühl, Jörg Dötsch, Franz Schaefer, Max Christoph Liebau
Clinical courses and complications of young adults with Autosomal Recessive Polycystic Kidney Disease (ARPKD). Scientific reports 9 (1) (2019)
Claudia Dafinger, Markus M Rinschen, Lori Borgal, Carolin Ehrenberg, Sander G Basten, Mareike Franke, Martin Höhne, Manfred Rauh, Heike Göbel, Wilhelm Bloch, F Thomas Wunderlich, Dorien J M Peters, Dirk Tasche, Tripti Mishra, Sandra Habbig, Jörg Dötsch, Roman-Ulrich Müller, Jens C Brüning, Thorsten Persigehl, Rachel H Giles, Thomas Benzing, Bernhard Schermer, Max Christoph Liebau
Targeted deletion of the AAA-ATPase Ruvbl1 in mice disrupts ciliary integrity and causes renal disease and hydrocephalus. Experimental & molecular medicine 50 (6) (2018)

Max Christoph Liebau.css-eqlu8i{font-size:small;padding-left:4px;} (Max C Liebau, Max Liebau)

Publication Activity (10 Years)

Top Topics

Top Venues

Max Christoph Liebau (Max C Liebau, Max Liebau)